We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
Department of Psychiatry, University of Geneva, Geneva, Switzerland; Laboratory of Neuropharmacology, University of the Balearic Islands,E- 07071Palma de Mal/orca, Spain
P.V. Escribá
Affiliation:
Department of Psychiatry, University of Geneva, Geneva, Switzerland; Laboratory of Neuropharmacology, University of the Balearic Islands,E- 07071Palma de Mal/orca, Spain
C. Walzer
Affiliation:
Department of Psychiatry, University of Geneva, Geneva, Switzerland; Laboratory of Neuropharmacology, University of the Balearic Islands,E- 07071Palma de Mal/orca, Spain
L. Balant
Affiliation:
Department of Psychiatry, University of Geneva, Geneva, Switzerland; Laboratory of Neuropharmacology, University of the Balearic Islands,E- 07071Palma de Mal/orca, Spain
A. Eytan
Affiliation:
Department of Psychiatry, University of Geneva, Geneva, Switzerland; Laboratory of Neuropharmacology, University of the Balearic Islands,E- 07071Palma de Mal/orca, Spain
J. Guimón
Affiliation:
Department of Psychiatry, University of Geneva, Geneva, Switzerland; Laboratory of Neuropharmacology, University of the Balearic Islands,E- 07071Palma de Mal/orca, Spain
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Comments
No Comments have been published for this article.